Sep 13, 2022 / 04:50PM GMT
Eric White Coldwell - Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst
Good afternoon, everyone. My name is Eric Coldwell, I cover pharma services for Baird. And it's a great pleasure. I've covered the distributors and Amerisource for a couple of decades now. It's always a pleasure to have this company with us, ABC, one of my favorite in the space, a very consistent performer over time relative to the chop we've seen in the overall marketplace. They may not love the definition, but I like to call them the tortoise versus the hare. Just tick shell steady eddy, goes in a straight line, a lot of fun. And I appreciate that consistency over time from you guys.
With us today, Jim Cleary, CFO. Also Bennett Murphy, of course, running up the Investor Relations group. And I am going to open it up to you, Jim, to just make a couple of very quick introductory comments. But I do know there was obviously some new news yesterday. So I'm going to ask you to address the acquisition that was announced 24 hours ago, PharmaLex, and maybe do that with your opening commentary so we
Amerisourcebergen Corp at Robert W Baird Global Healthcare Conference Transcript
Jan 22, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers